These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25726258)

  • 61. Acute effects of synthetic cannabinoids: Update 2015.
    Tournebize J; Gibaja V; Kahn JP
    Subst Abus; 2017; 38(3):344-366. PubMed ID: 27715709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
    Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
    AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
    Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2015 Jan; 80(20):5042-7. PubMed ID: 25730924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In Vitro Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid.
    Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
    Curr Neuropharmacol; 2016 Nov; ():. PubMed ID: 27829332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
    Liu C; Jia W; Hua Z; Qian Z
    Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.
    Monte AA; Calello DP; Gerona RR; Hamad E; Campleman SL; Brent J; Wax P; Carlson RG;
    J Med Toxicol; 2017 Jun; 13(2):146-152. PubMed ID: 28397128
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Schedules of Controlled Substances: Extension of Temporary Placement of THJ-2201, AB-PINACA and AB-CHMINACA in Schedule I of the Controlled Substances Act. Temporary order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Jan; 82(17):8590-2. PubMed ID: 28150924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of 5-Fluoro ADB in Human Whole Blood in Four Death Cases.
    Usui K; Fujita Y; Kamijo Y; Kokaji T; Funayama M
    J Anal Toxicol; 2018 Mar; 42(2):e21-e25. PubMed ID: 29186561
    [TBL] [Abstract][Full Text] [Related]  

  • 71. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York.
    Adams AJ; Banister SD; Irizarry L; Trecki J; Schwartz M; Gerona R
    N Engl J Med; 2017 Jan; 376(3):235-242. PubMed ID: 27973993
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
    Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
    ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mono-/polyintoxication with 5F-ADB: A case series.
    Kraemer M; Fels H; Dame T; Musshoff F; Halter S; Mogler L; Hess C; Madea B; Maas A
    Forensic Sci Int; 2019 Aug; 301():e29-e37. PubMed ID: 31138461
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Schedules of Controlled Substances: Extension of Temporary Placement of MAB–CHMINACA in Schedule I of the Controlled Substances Act. Temporary rule; temporary scheduling order; extension.
    Drug Enforcement Administration, Department of Justice.
    Fed Regist; 2018 Jan; 83(20):4411-2. PubMed ID: 29461023
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A survey of synthetic cannabinoid consumption by current cannabis users.
    Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
    Subst Abus; 2014; 35(2):184-9. PubMed ID: 24821356
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical features associated with ADB-BUTINACA exposure in patients attending emergency departments in England.
    King A; Hill SL; Pucci M; Bailey G; Keating L; Macfarlane R; Cantle F; Hudson S; Thomas SHL
    Clin Toxicol (Phila); 2022 Oct; 60(10):1094-1098. PubMed ID: 35943421
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of ADB-BUTINACA Metabolites in Human Urine, Blood, Kidney and Liver.
    Kavanagh P; Pechnikov A; Nikolaev I; Dowling G; Kolosova M; Grigoryev A
    J Anal Toxicol; 2022 Jul; 46(6):641-650. PubMed ID: 34341821
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011-2015, Ankara, Turkey.
    Göl E; Çok İ
    Forensic Sci Int; 2017 Nov; 280():124-129. PubMed ID: 29028489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.